Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor

Asthma Devices Companies

ID: MRFR/MED/1093-HCR
90 Pages
Nidhi Mandole
Last Updated: February 16, 2025
At the intersection of technology and respiratory health, Asthma Devices companies specialize in developing innovative devices for managing and treating asthma. These organizations contribute to improved quality of life for individuals with asthma through effective and user-friendly solutions.
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Asthma Devices Market

Market Size

Forecast Period2025 - 2035
CAGR (2025 - 2035)6.71%
2024 Market Size$ 4.27 Billion
2025 Market Size$ 4.56 Billion
2035 Market Size$ 8.72 Billion

Key Players

GlaxoSmithKline
AstraZeneca
Boehringer Ingelheim
Novartis
Teva Pharmaceutical Industries
Merck & Co.
Opportunities
  • Rising Prevalence of Asthma
  • Increased Awareness and Education
  • Regulatory Support for Innovative Devices

Top Industry Leaders in the Asthma Devices Market

Asthma Devices Market
ย 

Latestย Asthma Devicesย Companiesย Updates:

Flovent Discontinuation: GSK's discontinuation of Flovent HFA, a popular corticosteroid inhaler, at the start of 2024, has caused concerns for patients facing insurance hurdles and potential cost issues with the authorized generic version.

Symbicort Transition: AstraZeneca announced the planned discontinuation of Symbicort in certain markets by 2025, focusing on newer inhaled corticosteroid/long-acting beta-agonist (ICS/LABA) combinations like Breztri Aerosphere.

Teva's ProAir Respiclar 160HFA Approval: The FDA approved Teva's generic version of ProAir Respiclar 160 HFA, an albuterol rescue inhaler, offering a potential cost-effective option for patients.

Trudell Medical's Trudell Medical Microhaler Launch: Trudell Medical launched its Microhaler, a new dry powder inhaler designed for easier portability and use, particularly for children and elderly patients.

List ofย Asthma Devicesย Key companies in the market:

  • GlaxoSmithKline plc. (Europe)
  • Merck & Co., Inc. (U.S.)
  • 3M (U.S.)
  • Aristopharma Ltd. (Asia Pacific)
  • SRS PHARMACEUTICALS PVT. LTD. (Asia Pacific)
  • AstraZeneca (Europe), Baxter. (U.S.)
  • Boehringer Ingelheim GmbH (Europe)
  • Koninklijke Philips N.V. (Europe)